BACKGROUND: Galactose-1-phosphate:uridyltransferase (GALT) catalyses the conversion of galactose-1-phosphate (Gal-1-P) and UDP-glucose (UDP-Glc) into glucose-6-phosphate and UDP-galactose (UDP-Gal). Complete, or near complete, deficiency of GALT causes classic galactosaemia. The diagnosis is confirmed by measuring GALT activity in erythrocytes. The most commonly used assays require radio labelled substrates or indirect coupled assays. METHODS: GALT activity was measured in erythrocyte lysates using optimal concentrations of the substrates galactose-1-phosphate and UDP-Glc. UDP-Gal and UDP-Glc were separated using reversed-phase high performance liquid chromatography with UV detection. Clinical validity was assessed using blood samples from galactosaemic patients. RESULTS: UDP-Gal and UDP-Glc were separated with HPLC. The assay was linear with incubation times up 80 min and between 0 and 42.5 nmol haemoglobin. Within-day and between-day imprecision at 50, 75 and 100% enzyme activity was <1.4% and <2.4%, respectively. Mean GALT activity in 33 individuals was 601+/-79 nmol UDP-Gal/(micromol Hb.h) (range 492-697). Patients with classical galactosaemia were easily detected by their extremely low activity. CONCLUSIONS: We have developed a reliable and convenient direct method to measure GALT activity in human erythrocytes using HPLC with UV detection. Copyright 2010 Elsevier B.V. All rights reserved.
BACKGROUND:Galactose-1-phosphate:uridyltransferase (GALT) catalyses the conversion of galactose-1-phosphate (Gal-1-P) and UDP-glucose (UDP-Glc) into glucose-6-phosphate and UDP-galactose (UDP-Gal). Complete, or near complete, deficiency of GALT causes classic galactosaemia. The diagnosis is confirmed by measuring GALT activity in erythrocytes. The most commonly used assays require radio labelled substrates or indirect coupled assays. METHODS:GALT activity was measured in erythrocyte lysates using optimal concentrations of the substrates galactose-1-phosphate and UDP-Glc. UDP-Gal and UDP-Glc were separated using reversed-phase high performance liquid chromatography with UV detection. Clinical validity was assessed using blood samples from galactosaemic patients. RESULTS:UDP-Gal and UDP-Glc were separated with HPLC. The assay was linear with incubation times up 80 min and between 0 and 42.5 nmol haemoglobin. Within-day and between-day imprecision at 50, 75 and 100% enzyme activity was <1.4% and <2.4%, respectively. Mean GALT activity in 33 individuals was 601+/-79 nmol UDP-Gal/(micromol Hb.h) (range 492-697). Patients with classical galactosaemia were easily detected by their extremely low activity. CONCLUSIONS: We have developed a reliable and convenient direct method to measure GALT activity in human erythrocytes using HPLC with UV detection. Copyright 2010 Elsevier B.V. All rights reserved.
Authors: Cynthia S Gubbels; Corrine K Welt; John C M Dumoulin; Simon G F Robben; Catherine M Gordon; Gerard A J Dunselman; M Estela Rubio-Gozalbo; Gerard T Berry Journal: J Inherit Metab Dis Date: 2012-10-11 Impact factor: 4.982
Authors: Ana I Coelho; Sílvia Lourenço; Matilde Trabuco; Maria João Silva; Anabela Oliveira; Ana Gaspar; Luísa Diogo; Isabel Tavares de Almeida; João B Vicente; Isabel Rivera Journal: Eur J Hum Genet Date: 2014-07-23 Impact factor: 4.246
Authors: Ana I Coelho; Matilde Trabuco; Ruben Ramos; Maria João Silva; Isabel Tavares de Almeida; Paula Leandro; Isabel Rivera; João B Vicente Journal: Mol Genet Genomic Med Date: 2014-06-23 Impact factor: 2.183
Authors: Jo M Vanoevelen; Britt van Erven; Jörgen Bierau; Xiaoping Huang; Gerard T Berry; Rein Vos; Ana I Coelho; M Estela Rubio-Gozalbo Journal: J Inherit Metab Dis Date: 2017-09-14 Impact factor: 4.982
Authors: Minela Haskovic; Britt Derks; Liesbeth van der Ploeg; Jorn Trommelen; Jean Nyakayiru; Luc J C van Loon; Sabrina Mackinnon; Wyatt W Yue; Roy W A Peake; Li Zha; Didem Demirbas; Wanshu Qi; Xiaoping Huang; Gerard T Berry; Jelle Achten; Jörgen Bierau; M Estela Rubio-Gozalbo; Ana I Coelho Journal: Orphanet J Rare Dis Date: 2018-11-26 Impact factor: 4.123
Authors: Elena Perenthaler; Anita Nikoncuk; Soheil Yousefi; Woutje M Berdowski; Maysoon Alsagob; Ivan Capo; Herma C van der Linde; Paul van den Berg; Edwin H Jacobs; Darija Putar; Mehrnaz Ghazvini; Eleonora Aronica; Wilfred F J van IJcken; Walter G de Valk; Evita Medici-van den Herik; Marjon van Slegtenhorst; Lauren Brick; Mariya Kozenko; Jennefer N Kohler; Jonathan A Bernstein; Kristin G Monaghan; Amber Begtrup; Rebecca Torene; Amna Al Futaisi; Fathiya Al Murshedi; Renjith Mani; Faisal Al Azri; Erik-Jan Kamsteeg; Majid Mojarrad; Atieh Eslahi; Zaynab Khazaei; Fateme Massinaei Darmiyan; Mohammad Doosti; Ehsan Ghayoor Karimiani; Jana Vandrovcova; Faisal Zafar; Nuzhat Rana; Krishna K Kandaswamy; Jozef Hertecant; Peter Bauer; Mohammed A AlMuhaizea; Mustafa A Salih; Mazhor Aldosary; Rawan Almass; Laila Al-Quait; Wafa Qubbaj; Serdar Coskun; Khaled O Alahmadi; Muddathir H A Hamad; Salem Alwadaee; Khalid Awartani; Anas M Dababo; Futwan Almohanna; Dilek Colak; Mohammadreza Dehghani; Mohammad Yahya Vahidi Mehrjardi; Murat Gunel; A Gulhan Ercan-Sencicek; Gouri Rao Passi; Huma Arshad Cheema; Stephanie Efthymiou; Henry Houlden; Aida M Bertoli-Avella; Alice S Brooks; Kyle Retterer; Reza Maroofian; Namik Kaya; Tjakko J van Ham; Tahsin Stefan Barakat Journal: Acta Neuropathol Date: 2019-12-09 Impact factor: 17.088